NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
8.98
+0.46 (5.46%)
At close: Aug 1, 2025, 4:00 PM
8.99
+0.02 (0.17%)
After-hours: Aug 1, 2025, 4:10 PM EDT
CALT Market Cap
NeuroPace has a market cap or net worth of $294.86 million as of August 1, 2025. Its market cap has increased by 36.48% in one year.
Market Cap
294.86M
Enterprise Value
301.75M
1-Year Change
36.48%
Ranking
Category
Stock Price
$8.98
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $294.86M, a decrease of -25.03%. That is a compound annual growth rate of -6.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 294.86M | -11.72% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |